Change over period: —
NSE · CLEDUCATE
CLEDUCATE
-43.0% from the 52-week high · +35.9% above the low
CL Educate Ltd. is a holding company, which engages in the provision of education products, services, content, and infrastructure across education value chain. The company is headquartered in New Delhi, Delhi and currently employs 354 full-time employees. The company went IPO on 2017-03-31. The Company’s segments include EdTech and MarTech. Under the EdTech segment it serves various products which can be categorized into: Test Preparation, Platform Monetization and Content Monetization. For the MarTech segment, under the brand name Kestone, the Company offers services to corporates: Experiential Marketing & Event Management Solutions, Digital & MarComm services, Customized Engagement Programs, Transitioning Businesses into the Metaverse and Strategic Business Solutions. Its Platform Monetization offers various educational institutions an array of its products, such as Integrated solutions to educational institutions & universities across India, Student Recruitment Services and Research & Incubation Services. Its test preparation provides Career Launcher offers various products through its digital and business partner channels of distribution.
The short version. CLEDUCATE reported revenue of ₹170 crore for Sep 2026, up 3.7% from a year earlier. Net profit was ₹8 crore (up 60.0% year on year). Return on equity was -10.2% in Mar 2026. Promoter holding was 51.72% in Sep 2026, down 1.42 points over 8 quarters.
1 · The price
How has the stock traded?
CLEDUCATE trades 43.0% below its 52-week high and 35.9% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹170 cr.
Sep 2026 net profit of ₹8 cr.
1.7 pts higher than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 170 | 128 | 118 | 120 | 164 | 146 | 97 | 71 |
| Net profit | 8 | -2 | -10 | -17 | 5 | -4 | -16 | -3 |
| Net margin % | 4.9 | -1.2 | -8.7 | -14.0 | 3.2 | -2.6 | -16.8 | -3.7 |
| EPS (₹) | 1.55 | -0.28 | -1.9 | -3.12 | 0.96 | -0.71 | -3.03 | -0.49 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 548 | 358 | 319 | 291 | 207 | 184 | 309 | 339 |
| Net profit | -26 | -11 | 15 | 23 | 14 | -12 | -53 | 20 |
| Net margin % | -4.7 | -3.1 | 4.7 | 7.7 | 6.6 | -6.3 | -17.2 | 5.9 |
| EPS (₹) | -4.77 | -2.08 | 2.79 | 4.09 | 2.43 | -2.06 | -9.38 | 3.52 |
3 · The quality
How well does it turn capital into profit?
Return on equity was -10.2% in Mar 2026; debt to equity is 0.92.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | -10.2 | -4.1 | 5.4 | 8.2 |
| Return on capital % | 4.8 | 1.2 | 8.6 | 7.2 |
| EBITDA margin % | 11.3 | 7.7 | 11.8 | 10.7 |
| Net margin % | -4.5 | -3.0 | 4.5 | 7.6 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 24.1% | 24.0% |
| Profit CAGR | — | 17.2% |
4 · The owners
Who holds it, and are they adding?
Down 1.42 pts over 8 quarters.
Down 0.41 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.14 | 53.16 | 53.16 | 51.78 | 51.78 | 51.78 | 51.78 | 51.72 | -1.42 |
| FII | 8.2 | 8.12 | 7.98 | 7.99 | 7.87 | 7.89 | 7.8 | 7.79 | -0.41 |
| DII | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 38.66 | 38.7 | 38.86 | 40.23 | 40.35 | 40.32 | 40.41 | 40.49 | +1.83 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for CLEDUCATE are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Other Consumer Services stocks
Quick answers
Common questions about CLEDUCATE
What is the CLEDUCATE share price?
CLEDUCATE (CLEDUCATE) last closed at ₹52.95, up 2.34% on the day. Its 52-week range is ₹38.06 to ₹90.71.
What is the market cap of CLEDUCATE?
CLEDUCATE has a market capitalisation of about ₹279 crore.
How are CLEDUCATE's latest results?
CLEDUCATE reported revenue of ₹170 crore for Sep 2026, up 3.7% from a year earlier. Net profit was ₹8 crore (up 60.0% year on year). Return on equity was -10.2% in Mar 2026. Promoter holding was 51.72% in Sep 2026, down 1.42 points over 8 quarters.
Who owns CLEDUCATE?
As of Sep 2026, shareholding was: Promoter 51.72%, FII 7.79%, Public 40.49%.
How many mutual funds hold CLEDUCATE?
0 mutual fund schemes held CLEDUCATE in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 16 Dec 2022 · Bonus issue 1:1
- 30 Sep 2021 · Stock Split From Rs.10/- to Rs.5/-
- 22 Nov 2019 · Interim Dividend - Rs. 1
- 14 Aug 2018 · Interim Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.